Abstract. Dual detection of α-fetoprotein (AFP) and free β-human chorionic gonadotropin (β-HCG) is a common screening method for Down syndrome in the second trimester and its efficacy is assessed by false-positive rate (FPR). The present study aimed to investigate the effects of the bias in median multiple of the median (mMoM) values of AFP and free β-HCG on FPR. The bias in mMoM values of AFP and free β-HCG and the bias in mMoM values under different gestational ages and weight groups were analyzed. Median equations were adjusted, and medians in LifeCycle software were replaced by local medians. Following two adjustments of the median equations, all indices including FPR, mMoM values of markers and mMoM values under different gestational ages and weight groups generally reached an ideal state. In conclusion, abnormal bias in mMoM values may prompt aberrant application of median equations, and regular monitoring of these indicators may be important for quality control in prenatal screening.
Introduction
Down syndrome is considered to be the most common disease among prenatal chromosome abnormalities (1) . Prenatal serological screening is an effective method for decreasing the birth of prevalence of children with Down syndrome, and adequate quality control of the screening is important to maintain its efficiency (2) . Prenatal screening for Down syndrome involves coordination of multiple clinical sectors, and its efficiency depends on a variety of factors, including clinical data collection, serum and treatment, detection method and risk calculation. Due to numerous and uncertain factors, it is difficult to monitor the complete process of prenatal screening for Down syndrome (3) (4) (5) .
Second-trimester biochemical screening methods include the detection of dual serological indicators, namely α-fetoprotein (AFP) combined with total human chorionic gonadotropin (HCG) or free β-HCG (6, 7) , a triple test for AFP, unconjugated estriol (uE3) and HCG (8) , and a quadruple test for AFP, HCG (total or free β-), uE3 and inhibin-A (9) . The median multiple of the median (mMoM) value for different markers is considered to be a standard metric as it responds to the quality of data effectively. The detection rate (DR) and false positive rate (FPR) are also considered to be effective evaluation indices of screening efficiency, though they may be affected by the bias in MoM values of distinct markers (8) . Nix et al (10) identified that if there was a bias of 10% in MoM value for individual markers, there would be a 4-fold increase in risk of Down syndrome determined via the triple test. For instance, if a risk was 1/1,000 and all three markers had a 10% bias in MoM values towards Down syndrome, the risk would be 1/361. The risk threshold changed from 1/250 to 1/692.5, meanwhile FPR and DR increased simultaneously. If the risk threshold was 1/250, FPR and DR were 5.8 and 75.6%, respectively. Considering a risk threshold of 1/692.5, FPR would be 13.5% and DR would be 86.9%, thus increasing FPR by 7.7% and DR by 11.3%. These data indicated that even a 5% bias in a single marker would lead to up to a 2% change in FPR (10) . Increased FPR is a source of mental stress for pregnant women, as well as being wasteful in terms of medical resources and cost. Therefore, it is important to observe FPR and mMoM values regularly to maintain effective screening quality. The present study aimed to evaluate the practical bias phenomenon in mMoM values at the Nanjing Maternity and Child Health Care Hospital (Nanjing, China), and to determine strategies of reducing the bias in order to improve screening and provide improved quality control management. Table I . Initially, only gestational age and weight median equations for AFP were adjusted, as well as the weight median equation for free β-HCG based on the study cohort data from January 2014 to August 2015. Medians embedded in LifeCycle software version 4.0 (PerkinElmer, Inc.) were replaced by medians calculated according to the local data from January 2014 to August 2015. However, it was identified that mMoM values of free β-HCG in the next months (September 2015 to March 2016) had increased bias compared with the values from the preceding months. Thus, both gestational and weight median equations for free β-HCG were adjusted using the study cohort data from January 2014 to December 2015. The medians embedded in the LifeCycle software were then replaced by the medians calculated over this time period. The data from January 2014 to December 2016 was retrospectively analyzed applying the adjusted median equations. Whether the adjustment was appropriate was verified by comparing FPR, mMoM values of AFP and free β-HCG markers, and mMoM values of AFP and free β-HCG under different gestational ages and different weight groups prior to and following the adjustments of the median equations.
Materials and methods

Population selection.
Cumulative sum control (CUSUM) chart analysis.
A CUSUM chart accumulates and magnifies the bias occurring during a detection process. When the mean value of the measured results coincides with the expected value, the cumulative trend is parallel to the time axis. When the deviation of the mean value from the expected value is positive, the cumulative trend inclines upwards and vice versa. The larger the difference between the measured result and the expected value, the greater the accumulation and the steeper the inclination of the graph. By observing the change in the slope of the curve, the change and the starting point of the change can be identified (13, 14) . The current study analyzed whether the change was consistent with mMoM values of AFP and free β-HCG, and its function in quality control was evaluated.
Statistical analysis. SPSS 17.0 software (SPSS, Inc., Chicago, IL, USA) was used for statistical analysis. Independent samples t-tests were used for analysis of data significance, Data was presented as the mean ± two standard deviations and P<0.05 was considered to indicate a statistically significant difference.
Results
FPR increase and bias in mMoM values of AFP and free β-HCG markers.
FPR is a quality control aspect of serological screening, which in the current study was identified to be ~5% between January 2014 and April 2015 (4.80±1.08), though was comparatively higher from May 2015 (5.74±1.20; P>0.05; Fig. 1A ). Subsequently, the detection precision and accuracy factors that may lead to an increased FPR, including serum processing and testing, and gestational age projections, were excluded, and the mMoM values of AFP and free β-HCG markers were retrospectively analyzed. (Fig. 2A) . The gestational age median equation of free β-HCG was not changed at this time, as there was no apparent unsuitability using the median equation y=10^(-4.53 412+0.270717*GA-0.00398489*GA^2+0.0000237835*GA^3-0.0000000510437*GA^4) provided by the LifeCycle software (Fig. 2B) . For the weight median equation, it was identified that both calibrations were inadequate (Table II (Table II) . However, correcting the body weight median equation and medians in LifeCycle software for free β-HCG did not achieve the desired effect. From September 2015 to March 2016 following this adjustment, FPR was sustained at a high level (Fig. 3A) , and while mMoM values of AFP marker fluctuated randomly in the range 0.95-1.05 (Fig. 3B) , greater deviation in mMoM values of free β-HCG occurred under different gestational ages (Fig. 2B ) and different weight groups (Table II) (Fig. 3C) . It was determined that by only changing the median equation of weight of free β-HCG in September 2015, bias of free β-HCG also existed, and thus the weight median equation was adjusted as y=2.416-0.03435*weight+0.0001674 *weight^2, and the gestational age median equation as y=10( 3.59566-0.030088*GA+0.0000794176*GA^2) in March 2016 according to data from January 2014 to December 2015, and the medians of the software were also adjusted according to data from January 2014 to December 2015. Subsequently, the mMoM values of free β-HCG marker came to an ideal distribution state (Fig. 3D) , fluctuating between ~0.95-1.05, and even the mMoM values of free β-HCG under different gestational ages (Fig. 2B ) and different weights (Table II) returned to normal range after these measures. Additionally, the FPR from April 2016 to December 2016 returned to an acceptable range (Fig. 3A) .
Significance of CUSUM chart in screening quality control.
CUSUM charts were considered effective for responding to quality control, as they changed consistently with the adjustments performed. From June 2014 to December 2014, the slope of the curve in the CUSUM charts of AFP (Fig. 4A) continued to decline, and mMoM values of AFP remained low (Fig. 1B) . Due to the lack of data for the CUSUM chart at that time, the corresponding response was not determined. After this time, the slope of the curve underwent positive and negative fluctuations, and continuous increases or decreases were not apparent. After December 2015, the curve became relatively proximal to the horizontal line, indicating that the detection of AFP was stable and the adjustment of the relevant median equation was effective (Fig. 4A) . A different phenomenon was observed for free β-HCG (Fig. 4B) . The curve was relatively close to the horizontal line from June 2014 to May 2015, but the slope of the curve continued upward after May 2015, indicating that some significant factor may have lead to the increase in free β-HCG while FPR increased and bias in Table II . mMoM values of AFP and free β-HCG prior to and following weight equation adjustment. 
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Discussion
Screening efficiency is represented by both DR and FPR. Prenatal serological screening may result in false negatives, which can not be determined until after childbirth, and thus regarding quality control in prenatal screening, DR seems inadequate for immediate quality control. By contrast, FPR reflects screening quality immediately, and thus may be considered more meaningful in quality control. In the current study, a significantly elevated FPR was first identified, after which the factors that may have caused this were analyzed, including bias in the mMoM values of AFP and free β-HCG markers, and in the mMoM values of AFP and free β-HCG under different gestational ages and weight groups. The present results were similar to those reported by Nix et al (10) , in that a rise in FPR and bias in mMoM values AFP and free β-HCG toward Down's syndrome were identified. However, an increase in FPR may increase the number of invasive prenatal examinations, the psychological burden to pregnant women and medical pressure, and thus corresponding assessments were performed. The median equations of gestational age and weight of AFP and the weight median equation of free β-HCG were modified based on local data, while the gestational age median equation of free β-HCG was not adjusted in the first instance. In the follow-up work, FPR was markedly increased and abnormally high fluctuations in mMoM values of free β-HCG were observed. After a half-year period of observation, and following the exclusion of all possible factors that may cause the fluctuation, gestational age and weight median equations for free β-HCG were modified together. All indices including FPR, mMoM values of markers and mMoM values under different gestational ages and weight groups generally reached an ideal state. The corresponding results indicated that gestational age and weight median equations must be adjusted together and not alone. Additionally in the present study, the significant changes in FPR and mMoM values indicated that there maybe some factor that was influencing screening. Therefore, risk assessment should be performed if there are no clear influencing factors from the start of screening to the laboratory analysis. For prenatal screening and screening management, screening data analysis is important for the quality control of the screening system. Firstly, by focusing on abnormal changes in screening FPR and mMoM values of markers, bias maybe identified immediately, which will aid to find the confounding factor at the earliest opportunity. Secondly, analysis based on local mMoM values was the basis for the modification of the median equation. Ethnic, geographical and other factors may lead to differences in mMoM values of serological indicators; therefore, establishing gestational age and weight median equations by the median acquired from normal pregnant women in the local region is important. However, how to modify the median equation is not simple and must be based on comprehensive data, accurate laboratory test results and reliable risk assessment. Thus, medians must be obtained under strict quality control. Thirdly, monitoring of all indices including FPR, mMoM values of markers and mMoM values under different gestational ages and weight groups is a reliable method for laboratory quality evaluation. According to this method, an independently standardized data audit method maybe established to determine a unified quality assessment method in domestic screening agencies (11) . Finally, FPR and mMoM values may be applied to demonstrate a stable screening efficiency of the screening system, and horizontal quality evaluation could be performed among screening agencies. Taken together, the present data analysis techniques may make the screening more reliable in routine clinical together practice in the future.
